MEDICENNA THERAPEUTICS CORP (MDNA)
CA58490H1073 - Common Stock
| TTM (2023-6-30) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.76M | -10.05M | -22.58M | -17.29M | -8.28M | |||
| Depreciation Amortization | 5.00K | 4.00K | 38.00K | 40.00K | 10.00K | |||
| Change In Working Capital | 1.17M | 2.41M | -1.84M | 680.00K | -790.00K | |||
| Other non cash items | -6.24M | -5.02M | 799.00K | 1.26M | 110.00K | |||
| OPERATING CASH FLOW | -13.82M | -12.66M | -23.58M | -15.31M | -8.95M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | 0.00 | 10.05M | 5.01M | -15.00M | |||
| INVESTING CASH FLOW | N/A | 0.00 | 10.05M | 5.01M | -15.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -37.00K | -40.00K | 0.00 | |||
| Stock Issued/Repurchased | 23.79M | 24.76M | 3.92M | 18.30M | 40.75M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 3.54M | |||
| FINANCING CASH FLOW | 23.79M | 24.76M | 3.88M | 18.26M | 44.28M | |||
| Exchange Rate Effect | 340.00K | 958.00K | -184.00K | -280.00K | 0.00 | |||
| CHANGE IN CASH | 10.31M | 13.06M | -9.84M | 7.68M | 20.33M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.82M | -12.66M | -23.58M | -15.31M | -8.95M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -13.82M | -12.66M | -23.58M | -15.31M | -8.95M | |||
All data in CAD